Tunnelled central venous catheter-induced thrombosis: A rare case of superior vena cava syndrome

Canadian Journal of Emergency Medicine

Volumn 7, Issue 4, 2005, Pages 273-277

  Aggarwal, Sandeep K ^a,c   McCauley, William ^b  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c NONE   (Canada)

Author keywords

Anticoagulation; Catheter induced thrombosis; Superior vena cava syndrome; Thrombolytics; Tunnelled central venous catheter

Indexed keywords

DALTEPARIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE; WARFARIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MAINTENANCE THERAPY; SUPERIOR CAVA VEIN SYNDROME; THROMBOSIS;

EID: 27944485802     PISSN: 14818035     EISSN: 14818035     Source Type: Journal    
DOI: 10.1017/S1481803500014433     Document Type: Article

References (40)

1. Moureau N, Poole S, Murdock MA, Gray SM, Semba CP. Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. J Vase Interv Radiol 2002;13:1009-16.
2. Schechter MM. The superior vena cava syndrome. Am J Med Sci 1954; 227:46-56.
3. Hunter W. The history of an aneurysm of the aorta with some remarks on aneurysms in general. Med Obstet Soc Phys (London) 1757;1:323.
4. Wudel JL Jr, Nesbitt JC. Superior vena cava syndrome. Curr Treat Options Oncol 2001;2:77-91.
5. De Cicco M, Matovic M, Balestreri L, Panarello G, Fantin D, Morassut S, et al. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res 1997;86:1 01-13.
6. Cimochowski GE, Worley E, Rutherford WE, Sartain J, Blondin J, Harter H. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 1990:54:154-61.
7. Puel V, Caudry M, Le Metayer P, Baste JC, Midy D, Marsault C. Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer 1993;72:2248-52.
8. Stanislav GV, Fitzgibbons RJ Jr, Bailey RT Jr, Mailliard JA, Johnson PS, Feole JB. Reliability of implantable central venous access devices in patients with cancer. Arch Surg 1987;122:1280-3.
9. Schwarz RE, Coit DG, Groeger JS. Transcutaneously tunneled central venous lines in cancer patients: an analysis of device-related morbidity factors based on prospective data collection. Ann Surg Oncol 2000;7:441-9.
10. Nightingale CE, Norman A, Cunningham D, Young J, Webb A, Filshie J. A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy. Eur J Cancer 1997;33:398-403.
11. Namyslowski J, Trerotola SO, McKusky M, Johnson MS, Shah H, Kraus M. Retrospective analysis of blood flow rates via tunneled right and left internal jugular vein dialysis catheters. Cardiovasc Intervent Radiol 1999;22 (suppl 2):S91.
12. Kuter DJ. Thrombotic complications of central venous catheters in cancer patients. Oncologist 2004;9:207-16.
13. Curelaru I, Bylock A, Gustavsson B, Hultman E, Under LE, Stefansson T, et al. Dynamics of thrombophlebitis in central venous catheterization via basilic and cephalic veins. Acta Chir Scand 1984; 150:285-93.
14. Lokich JJ, Becker B. Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy. Cancer 1983;52:1 586-9.
15. Markman M. Diagnosis and management of superior vena cava syndrome. Cleve Clin J Med 1999:66:59-61.
16. Sculier JP, Feld R. Superior vena cava obstruction syndrome: recommendations for management. Cancer Treat Rev 1985; 12:209-18.
17. Hoch JR. Management of the complications of long-term venous access. Semin Vase Surg 1997;10:135-43.
18. Lowell JA, Bothe A Jr. Central venous catheter related thrombosis. Surg Oncol Clin North Am 1995;4:479-92.
19. Adelstein DJ, Mines JD, Carter SG, Sacco D. Thromboembolic events in patients with malignant superior vena cava syndrome and the role of anticoagulation. Cancer 1988;62:2258-62.
20. Wudel JL Jr, Nesbitt JC. Superior vena cava syndrome. Curr Treat Options Oncol 2001;2:77-91.
21. Weber T, Huemer G, Tschernich H, Kranz A, Imhof M, Sladen RN. Catheter-induced thrombus in the superior vena cava diagnosed by transesophageal echocardiography. Acta Anaesthesiologica Scandinavica 1998;42:1227-30.
22. Nazarian GK, Foshager MC. Color Doppler sonography of the thoracic inlet veins. Radio Graphics 1995;1 5:1357-71.
23. Demondion X, Boutry N, Drizenko A, Paul C, Francke JP, Cotton A. Thoracic outlet: anatomic correlation with MR imaging. Am J Roentgenol 2000;1 75:417-22.
24. Shinde TS, Lee VS, Rofsky NM, Krinksy GA, Weinreb JC. Three-dimensional Gadolinium-enhanced MR venographic evaluation of patency of central veins in the thorax: initial experience. Radiology 1999;213:555-60.
25. Chen JC, Bongard F, Klein SR. A contemporary perspective on superior vena cava syndrome. Am J Surg 1990; 1 60:207-11.
26. Hirsh J, Dalen J, Guyatt G. The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians. Chest 2001;119 (suppl): 1S-2S.
27. Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PN, Arkin CF, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990; 112:423-8.
28. Boraks P, Seale J, Price J, Bass G, Ethell M, Keeling D, et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 1998;101:483-6.
29. Montreal M, Alastrue A, Bull M, Mira X, Muxart J, Rosell R, et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices - prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996;75:21-3.
30. Eastman ME, Khorsand M, Maki DG, Williams EC, Kim K, Sondel PM, et al. Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2. Cancer 2001;91:806-14.
31. Heaton DC, Man DY, Inder A. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern Med J 2002;32:84-8.
32. Teichgräber UK, Gebauer B, Benter T, Wagner HJ. Central venous access catheters: radiological management of complications. Cardiovasc Intervent Radiol 2003;26:321-33.
33. Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999;211:39-49.
34. Smith NL, Ravo B, Soroff HS, Khan SA. Successful fibrinolytic therapy for superior vena cava thrombosis secondary to long-term total parenteral nutrition. JPEN: J Parenteral Enteral Nutr 1985;9:55-7.
35. Gray BH, Olin JW, Graor RA, Young JR, Bartholomew JR, Ruschhaupt WF. Safety and efficacy of thrombolytic therapy for superior vena cava syndrome. Chest 1991 ;99:54-9.
36. Lawson M, Bottino JC, Hurtubise MR. The use of urokinase to restore patency of occluded central venous catheters. Am J Intraven Ther Clin Nutr 1982;9:29-32.
37. Gray RJ, Levitin A, Buck D, Brown LC, Sparling YH, Jablonski KA, et al. Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning well-positioned tunneled central venous dialysis catheters: a prospective, randomized trial. J Vase Interv Radiol 2000;11:1121-9.
38. Savader SJ, Ehrman KO, Porter DJ, Haikal LC, Oteham AC. Treatment of hemodialysis catheter-associated fibrin sheaths by rt-PA infusion: critical analysis of 124 procedures. J Vase Interv Radiol 2001;12:711-5.
39. Whigham CJ, Lindsey JI, Goodman CJ, Fisher RG. Venous port salvage utilizing low dose tPA. Cardiovasc Intervent Radiol 2002;25:513-6.
40. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003;348(12):1123-33.